000 01533 a2200445 4500
005 20250517050357.0
264 0 _c20160804
008 201608s 0 0 eng d
022 _a1432-1238
024 7 _a10.1007/s00134-015-4016-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPaskovaty, Alla
245 0 0 _aAntimicrobial de-escalation in septic cancer patients: is it safe to back down?
_h[electronic resource]
260 _bIntensive care medicine
_cNov 2015
300 _a2022-3 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAged
650 0 4 _aAnti-Infective Agents
_xadministration & dosage
650 0 4 _aCancer Care Facilities
_xstatistics & numerical data
650 0 4 _aCause of Death
650 0 4 _aDrug Resistance, Microbial
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHospital Mortality
650 0 4 _aHumans
650 0 4 _aIntensive Care Units
_xstatistics & numerical data
650 0 4 _aLength of Stay
_xstatistics & numerical data
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xcomplications
650 0 4 _aNew York City
_xepidemiology
650 0 4 _aRetrospective Studies
650 0 4 _aSepsis
_xdrug therapy
700 1 _aPastores, Stephen M
700 1 _aGedrimaite, Zivile
700 1 _aKostelecky, Natalie
700 1 _aRiedel, Elyn R
700 1 _aSeo, Susan K
773 0 _tIntensive care medicine
_gvol. 41
_gno. 11
_gp. 2022-3
856 4 0 _uhttps://doi.org/10.1007/s00134-015-4016-6
_zAvailable from publisher's website
999 _c25191984
_d25191984